<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2358">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05270408</url>
  </required_header>
  <id_info>
    <org_study_id>STU-2021-0974</org_study_id>
    <nct_id>NCT05270408</nct_id>
  </id_info>
  <brief_title>Noninvasive Brain Stimulation in Mild Cognitive Impairment and Dementia</brief_title>
  <official_title>Noninvasive Brain Stimulation in Mild Cognitive Impairment and Dementia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The research objective of this study is to examine the efficacy of HD-tDCS to the preSMA/DACC&#xD;
      region and its influence on verbal episodic memory in patients with MCI or dementia after 10&#xD;
      sessions of HD-tDCS. There will be three treatment arms: two active HD-tDCS (1 mA or 2 mA)&#xD;
      and a sham group. A verbal episodic memory task will be completed at baseline, immediately&#xD;
      following the last HD-tDCS session, and a 2-month follow-up.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot study being done to attempt to improve verbal episodic memory in persons with&#xD;
      mild cognitive impairment (MCI) and dementia. Although the hippocampus is a brain structure&#xD;
      most often associated with early deficits in MCI and dementia, the pre-supplemental motor&#xD;
      area (preSMA) and dorsal anterior cingulate cortex (DACC) have been shown to play a role in&#xD;
      verbal episodic memory for such patients. The purpose of this study is to examine the&#xD;
      efficacy of high-definition transcranial direct current stimulation (HD-tDCS) to the&#xD;
      preSMA/DACC region and its influence on verbal episodic memory in patients with MCI and&#xD;
      dementia. Entraining the preSMA/DACC circuit with 10 sessions at one of two levels of HD-tDCS&#xD;
      will allow the researchers to investigate whether neuromodulation may be used to improve&#xD;
      verbal episodic memory. Participants will receive 10 sessions at one of two levels of active&#xD;
      stimulation (1 mA or 2 mA anodal HD-tDCS targeting preSMA/DACC for 20 min) or sham across 2&#xD;
      weeks. The device is used to deliver high definition transcranial direct current stimulation&#xD;
      to targeted regions. A verbal episodic memory task will be completed at baseline, immediately&#xD;
      following the last HD-tDCS session, and a 2-month follow-up. The investigators plan to&#xD;
      recruit English-speaking participants aged 50 years and older with MCI and dementia.&#xD;
      Participants will be randomized into HD-tDCS conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 8, 2022</start_date>
  <completion_date type="Anticipated">January 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Score on the Rey Auditory Verbal Learning Test (RAVLT)</measure>
    <time_frame>Baseline, immediately following last treatment session, and 2-months post treatment</time_frame>
    <description>The RAVLT is a verbal episodic memory task where a list of 15 words is read aloud for 5 consecutive trials followed by a 20 minute delayed recall trial. The number of items recalled immediately after each trial are summed to create a total learning score, ranging from 0-75. Also, the number of items recalled for the delayed trial are recorded as a delayed recall score, ranging from 0-15. Higher scores reflect better episodic memory performance. Changes from baseline for the total learning and delayed recall scores at the last HD-tDCS session and the 2-month follow-up will be measured as the primary outcomes.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Alzheimer Disease</condition>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Dementia</condition>
  <arm_group>
    <arm_group_label>Active stimulation at 1mA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 1 mA active HD-tDCS for 20 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active stimulation at 2mA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 2 mA active HD-tDCS for 20 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants will receive sham HD-tDCS for 20 minutes, meaning no stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active Transcranial direct current stimulation (STARStim 8)</intervention_name>
    <description>Participants wear a neoprene cap on their head and electrodes filled with gel are attached and will deliver 1mA to the scalp.</description>
    <arm_group_label>Active stimulation at 1mA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active Transcranial direct current stimulation (STARStim 8)</intervention_name>
    <description>Participants wear a neoprene cap on their head and electrodes filled with gel are attached and will deliver 2mA to the scalp.</description>
    <arm_group_label>Active stimulation at 2mA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Transcranial direct current stimulation (STARStim 8)</intervention_name>
    <description>Participants wear a neoprene cap on their head and electrodes filled with gel are attached and will deliver no current to the scalp.</description>
    <arm_group_label>Sham group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 50 and older&#xD;
&#xD;
          2. Fluent in English&#xD;
&#xD;
          3. Active diagnosis of MCI or dementia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Substance use disorder&#xD;
&#xD;
          2. Has metal fragments in head&#xD;
&#xD;
          3. Taking medications that may interact with the HD-tDCS effect (i.e., amphetamines,&#xD;
             L-dopa, carbamazepine, sulpiride, pergolide, lorazepam, dextromethorphan,&#xD;
             D-cycloserine, flunarizine, or ropinirole)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian LoBue, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2022</verification_date>
  <study_first_submitted>December 30, 2021</study_first_submitted>
  <study_first_submitted_qc>February 25, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2022</study_first_posted>
  <last_update_submitted>August 22, 2022</last_update_submitted>
  <last_update_submitted_qc>August 22, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Christian Lobue</investigator_full_name>
    <investigator_title>ASSISTANT PROFESSOR</investigator_title>
  </responsible_party>
  <keyword>Transcranial direct current stimulation</keyword>
  <keyword>Alzheimer Disease</keyword>
  <keyword>Mild Cognitive Impairment</keyword>
  <keyword>Dementia</keyword>
  <keyword>MCI</keyword>
  <keyword>Mild neurocognitive disorder</keyword>
  <keyword>Amnestic</keyword>
  <keyword>Pre- alzheimer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

